Trials / Completed
CompletedNCT03817684
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Tetra Discovery Partners · Industry
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients with Early Alzheimer's Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BPN14770 | Drug BPN14770 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2019-04-30
- Primary completion
- 2020-02-04
- Completion
- 2020-02-04
- First posted
- 2019-01-25
- Last updated
- 2025-02-18
- Results posted
- 2025-02-18
Locations
41 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03817684. Inclusion in this directory is not an endorsement.